What we're reading, April 7, 2016: hospitals will help Louisiana pay for Medicaid expansion; Pfizer considers splitting the company after deal with Allergan falls through; and Pfizer gets 300 lawsuits dismissed.
Under new legislation being finalized in Louisiana, hospitals in the state will be charged a fee to help the state pay for Medicaid expansion. The Louisiana Hospital Association was in favor of expanding the program and supported the efforts to enact a fee to help pay, reported The Times-Picayune. The hospitals will be paying up to 40% of the cost of expansion and the fee will be reassessed each year.
After new rules aimed at the Pfizer-Allergan merger that used a controversial tax inversion were revealed earlier this week, the deal was called off. Now, Pfizer is considering an old plan first considered 5 years ago: splitting the company up, according to STAT. The split would create 2 entities: one that focused on the established business and produced older drugs, and one that focused on innovative business and produced newer and forthcoming products.
Just days after receiving the bad news from the Treasury Department, Pfizer got some good new regarding some lawsuits it was facing. A judge in Philadelphia dismissed more than 300 lawsuits alleging that Zoloft caused birth defects in children born to women who took the antidepressant while they were pregnant, reported Reuters. The judge ruled that the plaintiffs had not produced enough evidence showing a plausible link between the drug and the birth defects.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More